Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: The evidence for the involvement of alternatively activated macrophages

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Papackova, Zuzana ^a   Palenickova, Eliska ^a   Dankova, Helena ^a   Zdychova, Jana ^a   Skop, Vojtech ^b   Kazdova, Ludmila ^a   Cahova, Monika ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHLORIDE; GLUCOSE; MONOUNSATURATED FATTY ACID; PROTEIN KINASE C EPSILON; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CELL FUNCTION; CELL POPULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; KUPFFER CELL; LIPID DIET; LIPID METABOLISM; LIPOLYSIS; LYSOSOME; MACROPHAGE ACTIVATION; MALE; NONHUMAN; RAT; STEATOSIS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 84858710276     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-22     Document Type: Article

References (63)

1. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. Rector RS, Thyfault JP, Wei Y, Ibdah JA, World J Gastroenterol 2008 14 185 192 10.3748/wjg.14.185 18186553 (Pubitemid 351314297)
2. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Hotamisligil GS, Shargill NS, Spiegelman BM, Science 1993 259 87 91 10.1126/science.7678183 7678183 (Pubitemid 23036092)
3. M-1/M-2 macrophages and the Th1/Th2 paradigm. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM, J Immunol 2000 164 6166 6173 10843666 (Pubitemid 30408793)
4. Other functions, other genes: alternative activation of antigen-presenting cells. Goerdt S, Orfanos CE, Immunity 1999 10 137 142 10.1016/S1074-7613(00)80014-X 10072066 (Pubitemid 29115619)
5. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Fessler MB, Rudel LL, Brown JM, Curr Opin Lipidol 2009 20 379 385 10.1097/MOL.0b013e32832fa5c4 19625959
6. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A, Nature 2007 447 1116 1120 10.1038/nature05894 17515919 (Pubitemid 47014427)
7. Type of dietary fat and insulin resistance. Rivellese AA, De Natale C, Lilli S, Ann N Y Acad Sci 2002 967 329 335 12079860 (Pubitemid 34721918)
8. Diet and coronary heart disease: clinical trials. Brousseau ME, Schaefer EJ, Curr Atheroscler Rep 2000 2 487 493 10.1007/s11883-000-0048-6 11122783
9. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Munford RS, Hall CL, Science 1986 234 203 205 10.1126/science.3529396 3529396 (Pubitemid 17186099)
10. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Qureshi N, Takayama K, Kurtz R, Infect Immun 1991 59 441 444 1987057
11. Effect of the dietary fat quality on insulin sensitivity. Galgani JE, Uauy RD, Aguirre CA, Diaz EO, Br J Nutr 2008 100 471 479 10.1017/ S0007114508894408 18394213
12. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Gillingham LG, Harris-Janz S, Jones PJ, Lipids 2011 46 209 228 10.1007/s11745-010-3524-y 21308420
13. The influence of major dietary fatty acids on insulin secretion and action. Lopez S, Bermudez B, Abia R, Muriana FJ, Curr Opin Lipidol 2010 21 15 20 10.1097/MOL.0b013e3283346d39 19915461
14. Role of macrophage tissue infiltration in obesity and insulin resistance. Bourlier V, Bouloumie A, Diabetes Metab 2009 35 251 260 10.1016/j.diabet.2009. 05.001 19539513
15. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. Caballero F, Fernandez A, Matias N, Martinez L, Fucho R, Elena M, Caballeria J, Morales A, Fernandez-Checa JC, Garcia-Ruiz C, J Biol Chem 2010 285 18528 18536 10.1074/jbc.M109.099333 20395294
16. The liver as an immune organ. Sheth K, Bankey P, Curr Opin Crit Care 2001 7 99 104 10.1097/00075198-200104000-00008 11373518 (Pubitemid 32411398)
17. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Sun Z, Wada T, Maemura K, Uchikura K, Hoshino S, Diehl AM, Klein AS, Liver Transpl 2003 9 489 497 10.1053/jlts.2003.50091 12740792 (Pubitemid 36621718)
18. Liver immunobiology. Parker GA, Picut CA, Toxicol Pathol 2005 33 52 62 10.1080/01926230590522365 15805056 (Pubitemid 40216804)
19. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ, Hepatology 2003 38 1188 1198 10.1053/jhep.2003.50472 14578857 (Pubitemid 37314827)
20. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Vollmar B, Menger MD, Physiol Rev 2009 89 1269 1339 10.1152/physrev.00027.2008 19789382
21. Alternative activation of macrophages. Gordon S, Nat Rev Immunol 2003 3 23 35 10.1038/nri978 12511873 (Pubitemid 37328697)
22. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, Claussen B, Forster I, Brombacher F, Immunity 2004 20 623 635 10.1016/S1074-7613(04)00107-4 15142530 (Pubitemid 38659504)
23. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA, Biochim Biophys Acta 2009 1792 1062 1072 19699298
24. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM, Hepatology 1997 25 889 895 10.1002/hep.510250417 9096593 (Pubitemid 27157130)
25. Kupffer cell activation is a causal factor for hepatic insulin resistance. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA, Am J Physiol Gastrointest Liver Physiol 2010 298 107 116 10.1152/ajpgi.00391.2009 19875703
26. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Neyrinck AM, Cani PD, Dewulf EM, De Backer F, Bindels LB, Delzenne NM, Biochem Biophys Res Commun 2009 385 351 356 10.1016/j.bbrc.2009.05.070 19463788
27. NIH Guide to the Care and Use of Laboratory Animals. Committee for the Update of the Guide for the Care and Use of laboratory Animals, National Academies Press: NW Washington 8 2011
28. Development and evaluation of canine reference genes for accurate quantification of gene expression. Brinkhof B, Spee B, Rothuizen J, Penning LC, Anal Biochem 2006 356 36 43 10.1016/j.ab.2006.06.001 16844072 (Pubitemid 44232736)
29. The autophagy-lysosomal pathway is involved in TAG degradation in the liver: the effect of high-sucrose and high-fat diet. Cahova M, Dankova H, Palenickova E, Papackova Z, Kazdova L, Folia Biol (Praha) 2010 56 173 182
30. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. Belfrage P, Vaughan M, J Lipid Res 1969 10 341 344 5785006
31. In search of an "autophagometer". Rubinsztein DC, Cuervo AM, Ravikumar B, Sarkar S, Korolchuk V, Kaushik S, Klionsky DJ, Autophagy 2009 5 585 589 10.4161/auto.5.5.8823 19411822
32. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
33. Autophagy regulates lipid metabolism. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ, Nature 2009 458 1131 1135 10.1038/nature07976 19339967
34. Conversion of dense lysosomes into light lysosomes during hepatocytic autophagy. Seglen PO, Solheim AE, Exp Cell Res 1985 157 550 555 10.1016/0014-4827(85)90141-7 3979450 (Pubitemid 15035405)
35. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI, J Biol Chem 2004 279 32345 32353 10.1074/jbc.M313478200 15166226 (Pubitemid 39014687)
36. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE, Toxicol Sci 2007 96 2 15 17122412 (Pubitemid 46323203)
37. Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70. Andres D, Sanchez-Reus I, Bautista M, Cascales M, Biochem Pharmacol 2003 66 917 926 10.1016/S0006-2952(03)00443-X 12963478 (Pubitemid 37083588)
38. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. Muriel P, Escobar Y, J Appl Toxicol 2003 23 103 108 10.1002/jat.892 12666154 (Pubitemid 36417111)
39. Role of Kupffer cells in reperfusion injury in fat-loaded livers from ethanol-treated rats. Zhong Z, Connor HD, Mason RP, Qu W, Gao W, Lemasters JJ, Thurman RG, J Pharmacol Exp Ther 1995 275 1512 1517 8531123 (Pubitemid 26129944)
40. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR, J Immunol 2005 175 7661 7668 16301676 (Pubitemid 41713466)
41. Kupffer cell-depleted rats have a diminished acute-phase response following major liver resection. Prins HA, Meijer C, Boelens PG, Diks J, Holtz R, Masson S, Daveau M, Meijer S, Scotte M, van Leeuwen PA, Shock 2004 21 561 565 10.1097/01.shk.0000126649.96850.36 15167686
42. Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10. Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, Schmidt MG, van Rooijen N, Schnellmann RG, Chavin KD, J Immunol 2010 184 5849 5858 10.4049/jimmunol.0902024 20400698
43. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, Scott DK, O'Doherty RM, Diabetes 2010 59 347 357 10.2337/db09-0016 19934001
44. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. Cintra DE, Pauli JR, Araujo EP, Moraes JC, de Souza CT, Milanski M, Morari J, Gambero A, Saad MJ, Velloso LA, J Hepatol 2008 48 628 637 10.1016/j.jhep.2007.12.017 18267346
45. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H, J Clin Invest 2003 112 1821 1830 14679177 (Pubitemid 38063705)
46. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ, Science 2008 322 1539 1543 10.1126/science.1160794 19056984
47. TLR4 links innate immunity and fatty acid-induced insulin resistance. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS, J Clin Invest 2006 116 3015 3025 10.1172/JCI28898 17053832 (Pubitemid 44684486)
48. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S, Muller M, Hepatology 2010 51 511 522 10.1002/hep.23337 20054868
49. Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C theta and epsilon. Kewalramani G, Fink LN, Asadi F, Klip A, PLoS One 2011 6 26947 10.1371/journal.pone.0026947 22046423
50. Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Bilan PJ, Samokhvalov V, Koshkina A, Schertzer JD, Samaan MC, Klip A, Arch Physiol Biochem 2009 115 176 190 10.1080/ 13813450903079314 19671019
51. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP, Nat Immunol 2011 12 408 415 10.1038/ni.2022 21478880
52. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. Oliver E, McGillicuddy FC, Harford KA, Reynolds CM, Phillips CM, Ferguson JF, Roche HM, J Nutr Biochem 2011 http://dx.doi.org/10.1016./j.bbr. 2011.03.031
53. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. Mullen A, Loscher CE, Roche HM, J Nutr Biochem 2010 21 444 450 10.1016/j.jnutbio.2009.02.008 19427777
54. The role of tissue macrophages in the development of metabolic syndrome associated dysorders: the effect of high fat diet and the fatty acid composition). Papackova Z, Palenickova E, Dankova H, Cahova M, Kazdova L, Cas Lek Ces 2011 150 185 193
55. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. Lanthier N, Molendi-Coste O, Cani PD, van Rooijen N, Horsmans Y, Leclercq IA, FASEB J 2011 25 4301 4311 10.1096/fj.11-189472 21873555
56. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV Sr, Hevener AL, Farese RV Jr, Cell Metab 2007 6 69 78 10.1016/j.cmet.2007.05.005 17618857 (Pubitemid 46995777)
57. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman GI, Proc Natl Acad Sci USA 2011 108 16381 16385 10.1073/pnas.1113359108 21930939
58. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G, Cell Metab 2007 6 137 143 10.1016/j.cmet.2007.06.010 17681149 (Pubitemid 47189091)
59. Autophagy and cytokines. Harris J, Cytokine 2011 56 140 144 10.1016/j.cyto.2011.08.022 21889357
60. Specificity and other properties of lysosomal lipase of rat liver. Hayase K, Tappel AL, J Biol Chem 1970 245 169 175 5413966
61. Protein kinase C and lipid signaling for sustained cellular responses. Nishizuka Y, FASEB J 1995 9 484 496 7737456
62. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI, J Clin Invest 2007 117 739 745 10.1172/JCI30400 17318260 (Pubitemid 46348532)
63. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ, Diabetes 1997 46 169 178 10.2337/diabetes.46.2.169 9000691 (Pubitemid 27272248)